EFTA02121749Set 10
2013-11-089p2,318w
profit beats, progress in all divisions, guidance ahead, CMD 11/15 (trading +6.2%)
• Meda O3 revs & EBITDA light, EPS shade below, rev guidance in line, Dymista sales better
(trading
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02121749.pdf
EFTA02114020Set 10
2014-02-198p2,006w
Clariant Q4 revs fine, EBITDA better, net income below, confirms mit targets (trading -1.9%)
• Meda O4 sales better, adj EBITDA ahead, net income good, 10% organic growth (trading +7.3%)
• Temenos
https://www.justice.gov/epstein/files/DataSet%2010/EFTA02114020.pdf
EFTA02393498Set 11
2012-10-281p66w
Subject: reidluis natalia, lang, joffee vaiva, leon, ian,jeanluc, danielk, vic, meda,
lisa svenson, saarah, peggy „ boris, geffen, jagband , terje, mette, nadiak
reidluis natalia, lang, joffee vaiva, leon, ian,jeanluc
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02393498.pdf
EFTA02392850Set 11
2012-10-281p64w
Subject: reidluis r=3, lang, joffee vaiva, leon, ian,jeanluc, danielk, vit:æ meda,,
lisa svensone, peggy „ boris, geffen, jagband , terje, mette, nadiak
reidlui~ lang, joffee vaiva, leon, ian,jeanluc
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02392850.pdf